Company Filing History:
2 out of 15,488 
2 out of 1,327 
Years Active: 1996-2010
Title: The Innovations of Pietro Decamilli: Pioneering Diabetes Diagnosis and Treatment
Introduction
Pietro Decamilli, a notable inventor based in Guilford, CT, has made significant contributions to the field of diabetes research through his innovative patents. With a total of two patents to his name, Decamilli has focused on advancing methods for diagnosing and treating diabetes, highlighting the importance of early detection and effective management of this widespread disease.
Latest Patents
Decamilli's latest patents center on the methods for diagnosing diabetes and its prediabetic status. These assays involve exposing patient serum samples to purified ligands that can bind to autoantibodies specific for a 64 kD autoantigen found on pancreatic beta-cells. Typically, the purified ligand is glutamic acid decarboxylase (GAD) or an analog thereof. The patents emphasize the assays' ability to detect antibodies for both lower and higher molecular weight GAD, acknowledging that diabetic and prediabetic conditions may relate to only one of these forms. Furthermore, the treatment methods he devised include administering pharmaceutical compositions featuring the purified ligand, often combined with immunoglobulin or lymphoid cells to induce tolerance. Alternative approaches involve using attenuated T-helper cells or isolated T-cell receptors based on their reactivity with GAD.
Career Highlights
Throughout his career, Pietro Decamilli has collaborated with prominent institutions including the University of California and Yale University. His work in these esteemed organizations has fostered advancements in diabetes research, reflecting his dedication to improving patient outcomes through innovative solutions.
Collaborations
Decamilli has worked alongside esteemed colleagues such as Steinunn Baekkeskov and Henk-Jan Aanstoot. These collaborations have enriched his research and further established him as a respected figure in the field of biomedical innovation, particularly concerning diabetes.
Conclusion
Pietro Decamilli's contributions to diabetes diagnosis and treatment showcase the potential of innovative methods to change the landscape of medical care for individuals with diabetes. As he continues to develop and refine his patents, the impact of his work may lead to significant advancements in both the understanding and management of this chronic condition.